Pemetrexed in thoracic cancer

Expert Opinion on Pharmacotherapy
Hannelore Goeminne, Jan P van Meerbeeck

Abstract

Both lung cancer and mesothelioma are malignancies with increasing incidence, and both are primarily due to inhalation of an external carcinogen. The occurence of both diseases is expected to rise worldwide, although a stabilisation and/or decrease may be anticipated in some developed countries. There are other common similarities to both cancers, including the median age of their patients, the advanced stage at presentation, the outcome and the treatments given. This review focuses on the available evidence of a novel antifolate agent, pemetrexed, in the treatment of both of these thoracic malignancies. Current status, persisting controversies and future developments are discussed.

References

May 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K MattsonN van Zandwijk
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F J van BreukelenO Dalesio
Apr 15, 1988·International Journal of Cancer. Journal International Du Cancer·R SpirtasM A Tucker
Aug 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A P ChahinianL Leone
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R A Damhuis, T van Gelder
Feb 21, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T SahmoudG Giaccone
Feb 23, 1999·British Journal of Cancer·J PetoE Negri
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J ByrneB W Robinson
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R ThödtmannA R Hanauske
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J J RusthovenJ Iglesias
Jun 10, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C ManegoldK Krejcy
Apr 9, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J P van MeerbeeckUNKNOWN EORTC Lung Cancer Group
Apr 17, 2002·International Journal of Radiation Oncology, Biology, Physics·Marc BischofDetlev Latz
Jun 22, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S J ClarkeS P Ackland
Aug 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andy HughesHilary Calvert
Oct 26, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·T BerghmansJ P Sculier
Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giorgio V ScagliottiJames J Rusthoven
May 2, 2003·Expert Review of Anticancer Therapy·Alex A Adjei
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicholas J VogelzangPaolo Paoletti
Aug 26, 2003·Expert Review of Anticancer Therapy·Frances A Shepherd
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nasser HannaPaul A Bunn
Jun 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alex A Adjei
Jul 29, 2004·JAMA : the Journal of the American Medical Association·Catherine DelbaldoJean-Pierre Pignon
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christian MonneratDavid S Ettinger
Sep 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Walter WederRolf A Stahel
Jan 26, 2005·British Journal of Cancer·J T HodgsonJ Peto
Mar 10, 2005·The Annals of Pharmacotherapy·Katarzyna Puto, Jody S Garey
Apr 12, 2005·The Oncologist·Sarita Dubey, Joan H Schiller
Jul 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Giorgio V Scagliotti
Jul 12, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·T BerghmansUNKNOWN European Lung Cancer Working Party (ELCWP)
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group

❮ Previous
Next ❯

Citations

Nov 3, 2006·Expert Review of Neurotherapeutics·Jan Drappatz, Patrick Y Wen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Annals of Pharmacotherapy
Katarzyna Puto, Jody S Garey
Expert Opinion on Drug Metabolism & Toxicology
Jens Benn Sørensen
The Annals of Pharmacotherapy
Yanping Zhang, Lawrence A Trissel
The Annals of Pharmacotherapy
Yanping Zhang, Lawrence A Trissel
© 2022 Meta ULC. All rights reserved